Following the news that the UK has succeeded in eliminating measles, Dr Emma St Clair Pearce, the ABPI’s newly appointed Research and Collaboration Policy Officer, writes that while the UK’s success of limiting the spread of the virus through vaccination should be heralded, national figures for MMR...
Dr Sheuli Porkess, ABPI's Head of Medical Affairs, says:
The report published today by the Academy of Medical Sciences describes an urgent and serious challenge about how we ensure that patients, their carers and the healthcare professionals that support them, feel able to trust their medicines and the research evidence that underpins them.
A new report published today shows that the UK is trailing behind the rest of Europe in the treatment of cancer. British patients have worse survival rates after five years - the international benchmark for measuring the quality of cancer care – compared to the European average in nine out of ten...
It can take about 12 years and over £1 billion pounds to bring a medicine to the market. So with all this time, money and effort you might think that everything would be known about a medicine when it is launched on the market. But is this really the case?
Making sure patients continue to get the medicines they need is of upmost importance as we negotiate the UK’s withdrawal from the EU.
The UK pharmaceutical industry is passionate about the life sciences and we are always keen to encourage an interest in research. We recognise that the future of success for our industry and, more importantly, the future healthcare for patients in the UK, lies in the next generation.
The pharmaceutical industry typically employs doctors in very distinctive roles which can be related broadly to the medical responsibilities. Each role requires appropriate qualifications. Larger companies often employ specialists while, in smaller companies, some or all of the roles may be combined...
Medicines development is the process of formulating, testing and evaluating a potential new medicine as it moves from the laboratory to the clinic. Chemists, biologists and pharmacologists with a research science background usually undertake early research.
The majority of companies require physicians to be licensed with the General Medical Council (GMC) for entry into the industry, particularly in medical affairs roles.